nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—trigeminal nucleus—multiple sclerosis	0.199	0.346	CbGeAlD
Droperidol—HTR2A—trigeminal nerve—multiple sclerosis	0.0523	0.0908	CbGeAlD
Droperidol—HTR2A—pons—multiple sclerosis	0.0368	0.064	CbGeAlD
Droperidol—DRD2—nerve—multiple sclerosis	0.029	0.0503	CbGeAlD
Droperidol—HTR2A—pineal body—multiple sclerosis	0.0263	0.0457	CbGeAlD
Droperidol—HTR2A—peripheral nervous system—multiple sclerosis	0.0245	0.0426	CbGeAlD
Droperidol—Altered state of consciousness—Cladribine—multiple sclerosis	0.0195	0.0594	CcSEcCtD
Droperidol—HTR2A—nerve—multiple sclerosis	0.0191	0.0332	CbGeAlD
Droperidol—ADRA1A—brainstem—multiple sclerosis	0.0127	0.022	CbGeAlD
Droperidol—DRD2—brainstem—multiple sclerosis	0.0124	0.0216	CbGeAlD
Droperidol—DRD2—retina—multiple sclerosis	0.012	0.0208	CbGeAlD
Droperidol—Sudden death—Mitoxantrone—multiple sclerosis	0.0115	0.0352	CcSEcCtD
Droperidol—Cardiac arrest—Fingolimod—multiple sclerosis	0.0109	0.0334	CcSEcCtD
Droperidol—Depression—Fingolimod—multiple sclerosis	0.00884	0.027	CcSEcCtD
Droperidol—KCNH2—medulla oblongata—multiple sclerosis	0.00854	0.0148	CbGeAlD
Droperidol—HTR2A—brainstem—multiple sclerosis	0.0082	0.0142	CbGeAlD
Droperidol—DRD2—midbrain—multiple sclerosis	0.00793	0.0138	CbGeAlD
Droperidol—HTR2A—retina—multiple sclerosis	0.00791	0.0137	CbGeAlD
Droperidol—KCNH2—midbrain—multiple sclerosis	0.00781	0.0136	CbGeAlD
Droperidol—KCNH2—spinal cord—multiple sclerosis	0.00762	0.0132	CbGeAlD
Droperidol—Amenorrhoea—Mitoxantrone—multiple sclerosis	0.00672	0.0205	CcSEcCtD
Droperidol—ADRA1A—nervous system—multiple sclerosis	0.00665	0.0115	CbGeAlD
Droperidol—DRD2—nervous system—multiple sclerosis	0.00652	0.0113	CbGeAlD
Droperidol—KCNH2—nervous system—multiple sclerosis	0.00642	0.0111	CbGeAlD
Droperidol—ADRA1A—central nervous system—multiple sclerosis	0.0064	0.0111	CbGeAlD
Droperidol—DRD2—central nervous system—multiple sclerosis	0.00627	0.0109	CbGeAlD
Droperidol—ADRA1A—cerebellum—multiple sclerosis	0.00626	0.0109	CbGeAlD
Droperidol—KCNH2—central nervous system—multiple sclerosis	0.00618	0.0107	CbGeAlD
Droperidol—DRD2—cerebellum—multiple sclerosis	0.00613	0.0106	CbGeAlD
Droperidol—Palpitations—Fingolimod—multiple sclerosis	0.00612	0.0187	CcSEcCtD
Droperidol—KCNH2—cerebellum—multiple sclerosis	0.00604	0.0105	CbGeAlD
Droperidol—Hypertension—Fingolimod—multiple sclerosis	0.00598	0.0182	CcSEcCtD
Droperidol—Sudden death—Methotrexate—multiple sclerosis	0.00575	0.0175	CcSEcCtD
Droperidol—HTR2A—medulla oblongata—multiple sclerosis	0.00572	0.00993	CbGeAlD
Droperidol—Hypotension—Fingolimod—multiple sclerosis	0.00528	0.0161	CcSEcCtD
Droperidol—HTR2A—midbrain—multiple sclerosis	0.00523	0.00908	CbGeAlD
Droperidol—HTR2A—spinal cord—multiple sclerosis	0.0051	0.00885	CbGeAlD
Droperidol—ADRA1A—brain—multiple sclerosis	0.00508	0.00882	CbGeAlD
Droperidol—Amenorrhoea—Methylprednisolone—multiple sclerosis	0.00506	0.0154	CcSEcCtD
Droperidol—DRD2—brain—multiple sclerosis	0.00498	0.00865	CbGeAlD
Droperidol—KCNH2—brain—multiple sclerosis	0.00491	0.00852	CbGeAlD
Droperidol—Amenorrhoea—Betamethasone—multiple sclerosis	0.0046	0.014	CcSEcCtD
Droperidol—Amenorrhoea—Dexamethasone—multiple sclerosis	0.0046	0.014	CcSEcCtD
Droperidol—HTR2A—nervous system—multiple sclerosis	0.0043	0.00746	CbGeAlD
Droperidol—HTR2A—central nervous system—multiple sclerosis	0.00414	0.00718	CbGeAlD
Droperidol—Chills—Cladribine—multiple sclerosis	0.00405	0.0124	CcSEcCtD
Droperidol—HTR2A—cerebellum—multiple sclerosis	0.00404	0.00702	CbGeAlD
Droperidol—Amenorrhoea—Prednisone—multiple sclerosis	0.00401	0.0122	CcSEcCtD
Droperidol—Dizziness—Fingolimod—multiple sclerosis	0.00374	0.0114	CcSEcCtD
Droperidol—Cardiac arrest—Prednisolone—multiple sclerosis	0.00334	0.0102	CcSEcCtD
Droperidol—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.00334	0.0102	CcSEcCtD
Droperidol—Anxiety—Cladribine—multiple sclerosis	0.00333	0.0102	CcSEcCtD
Droperidol—Drowsiness—Mitoxantrone—multiple sclerosis	0.0033	0.0101	CcSEcCtD
Droperidol—Chills—Azathioprine—multiple sclerosis	0.00329	0.01	CcSEcCtD
Droperidol—HTR2A—brain—multiple sclerosis	0.00328	0.0057	CbGeAlD
Droperidol—Tachycardia—Cladribine—multiple sclerosis	0.00313	0.00954	CcSEcCtD
Droperidol—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00308	0.00938	CcSEcCtD
Droperidol—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00307	0.00936	CcSEcCtD
Droperidol—Hypotension—Cladribine—multiple sclerosis	0.003	0.00914	CcSEcCtD
Droperidol—Somnolence—Cladribine—multiple sclerosis	0.00285	0.00869	CcSEcCtD
Droperidol—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00279	0.00851	CcSEcCtD
Droperidol—Cardiac arrest—Betamethasone—multiple sclerosis	0.00279	0.00851	CcSEcCtD
Droperidol—Bronchospasm—Methylprednisolone—multiple sclerosis	0.00274	0.00837	CcSEcCtD
Droperidol—Chills—Mitoxantrone—multiple sclerosis	0.00266	0.00812	CcSEcCtD
Droperidol—Gynaecomastia—Methotrexate—multiple sclerosis	0.00263	0.00803	CcSEcCtD
Droperidol—Body temperature increased—Cladribine—multiple sclerosis	0.00253	0.00773	CcSEcCtD
Droperidol—Hypotension—Azathioprine—multiple sclerosis	0.00244	0.00743	CcSEcCtD
Droperidol—Cardiac arrest—Prednisone—multiple sclerosis	0.00243	0.00741	CcSEcCtD
Droperidol—Hypersensitivity—Cladribine—multiple sclerosis	0.00236	0.0072	CcSEcCtD
Droperidol—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00229	0.00698	CcSEcCtD
Droperidol—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00229	0.00698	CcSEcCtD
Droperidol—Hypertension—Mitoxantrone—multiple sclerosis	0.00223	0.0068	CcSEcCtD
Droperidol—Hallucination—Methylprednisolone—multiple sclerosis	0.00222	0.00678	CcSEcCtD
Droperidol—Anxiety—Mitoxantrone—multiple sclerosis	0.00219	0.00668	CcSEcCtD
Droperidol—Dizziness—Cladribine—multiple sclerosis	0.00212	0.00647	CcSEcCtD
Droperidol—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00211	0.00643	CcSEcCtD
Droperidol—Shock—Mitoxantrone—multiple sclerosis	0.00207	0.00632	CcSEcCtD
Droperidol—Body temperature increased—Azathioprine—multiple sclerosis	0.00206	0.00629	CcSEcCtD
Droperidol—Tachycardia—Mitoxantrone—multiple sclerosis	0.00206	0.00627	CcSEcCtD
Droperidol—Rash—Cladribine—multiple sclerosis	0.00202	0.00617	CcSEcCtD
Droperidol—Hallucination—Dexamethasone—multiple sclerosis	0.00202	0.00616	CcSEcCtD
Droperidol—Hallucination—Betamethasone—multiple sclerosis	0.00202	0.00616	CcSEcCtD
Droperidol—Dermatitis—Cladribine—multiple sclerosis	0.00202	0.00616	CcSEcCtD
Droperidol—Hyperglycaemia—Prednisone—multiple sclerosis	0.00199	0.00608	CcSEcCtD
Droperidol—Hypotension—Mitoxantrone—multiple sclerosis	0.00197	0.00601	CcSEcCtD
Droperidol—Depression—Prednisone—multiple sclerosis	0.00196	0.00599	CcSEcCtD
Droperidol—Angioedema—Prednisolone—multiple sclerosis	0.00194	0.0059	CcSEcCtD
Droperidol—Hypersensitivity—Azathioprine—multiple sclerosis	0.00192	0.00586	CcSEcCtD
Droperidol—Syncope—Prednisolone—multiple sclerosis	0.0019	0.00579	CcSEcCtD
Droperidol—Somnolence—Mitoxantrone—multiple sclerosis	0.00187	0.00571	CcSEcCtD
Droperidol—Loss of consciousness—Prednisolone—multiple sclerosis	0.00186	0.00568	CcSEcCtD
Droperidol—Hypertension—Prednisolone—multiple sclerosis	0.00183	0.00558	CcSEcCtD
Droperidol—Angioedema—Triamcinolone—multiple sclerosis	0.00178	0.00543	CcSEcCtD
Droperidol—Angioedema—Methylprednisolone—multiple sclerosis	0.00178	0.00542	CcSEcCtD
Droperidol—Hallucination—Prednisone—multiple sclerosis	0.00176	0.00537	CcSEcCtD
Droperidol—Syncope—Triamcinolone—multiple sclerosis	0.00175	0.00533	CcSEcCtD
Droperidol—Syncope—Methylprednisolone—multiple sclerosis	0.00174	0.00532	CcSEcCtD
Droperidol—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00173	0.00527	CcSEcCtD
Droperidol—Dizziness—Azathioprine—multiple sclerosis	0.00172	0.00526	CcSEcCtD
Droperidol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00171	0.00522	CcSEcCtD
Droperidol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00171	0.00521	CcSEcCtD
Droperidol—Shock—Prednisolone—multiple sclerosis	0.0017	0.00519	CcSEcCtD
Droperidol—Tachycardia—Prednisolone—multiple sclerosis	0.00169	0.00515	CcSEcCtD
Droperidol—Hypertension—Triamcinolone—multiple sclerosis	0.00168	0.00513	CcSEcCtD
Droperidol—Hypertension—Methylprednisolone—multiple sclerosis	0.00168	0.00512	CcSEcCtD
Droperidol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00167	0.00508	CcSEcCtD
Droperidol—Anxiety—Methylprednisolone—multiple sclerosis	0.00165	0.00503	CcSEcCtD
Droperidol—Drowsiness—Methotrexate—multiple sclerosis	0.00165	0.00502	CcSEcCtD
Droperidol—Rash—Azathioprine—multiple sclerosis	0.00164	0.00501	CcSEcCtD
Droperidol—Dermatitis—Azathioprine—multiple sclerosis	0.00164	0.00501	CcSEcCtD
Droperidol—Depression—Methotrexate—multiple sclerosis	0.00164	0.00501	CcSEcCtD
Droperidol—Angioedema—Betamethasone—multiple sclerosis	0.00162	0.00493	CcSEcCtD
Droperidol—Angioedema—Dexamethasone—multiple sclerosis	0.00162	0.00493	CcSEcCtD
Droperidol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00159	0.00485	CcSEcCtD
Droperidol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00159	0.00484	CcSEcCtD
Droperidol—Syncope—Dexamethasone—multiple sclerosis	0.00159	0.00484	CcSEcCtD
Droperidol—Syncope—Betamethasone—multiple sclerosis	0.00159	0.00484	CcSEcCtD
Droperidol—Shock—Triamcinolone—multiple sclerosis	0.00156	0.00477	CcSEcCtD
Droperidol—Shock—Methylprednisolone—multiple sclerosis	0.00156	0.00476	CcSEcCtD
Droperidol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00155	0.00474	CcSEcCtD
Droperidol—Loss of consciousness—Betamethasone—multiple sclerosis	0.00155	0.00474	CcSEcCtD
Droperidol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00155	0.00474	CcSEcCtD
Droperidol—Tachycardia—Triamcinolone—multiple sclerosis	0.00155	0.00473	CcSEcCtD
Droperidol—Tachycardia—Methylprednisolone—multiple sclerosis	0.00155	0.00472	CcSEcCtD
Droperidol—Hypertension—Dexamethasone—multiple sclerosis	0.00153	0.00465	CcSEcCtD
Droperidol—Hypertension—Betamethasone—multiple sclerosis	0.00153	0.00465	CcSEcCtD
Droperidol—Anxiety—Dexamethasone—multiple sclerosis	0.0015	0.00457	CcSEcCtD
Droperidol—Anxiety—Betamethasone—multiple sclerosis	0.0015	0.00457	CcSEcCtD
Droperidol—Hypotension—Methylprednisolone—multiple sclerosis	0.00148	0.00452	CcSEcCtD
Droperidol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00144	0.0044	CcSEcCtD
Droperidol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00144	0.0044	CcSEcCtD
Droperidol—Shock—Betamethasone—multiple sclerosis	0.00142	0.00433	CcSEcCtD
Droperidol—Shock—Dexamethasone—multiple sclerosis	0.00142	0.00433	CcSEcCtD
Droperidol—Tachycardia—Betamethasone—multiple sclerosis	0.00141	0.00429	CcSEcCtD
Droperidol—Tachycardia—Dexamethasone—multiple sclerosis	0.00141	0.00429	CcSEcCtD
Droperidol—Angioedema—Prednisone—multiple sclerosis	0.00141	0.00429	CcSEcCtD
Droperidol—Syncope—Prednisone—multiple sclerosis	0.00138	0.00421	CcSEcCtD
Droperidol—Loss of consciousness—Prednisone—multiple sclerosis	0.00135	0.00413	CcSEcCtD
Droperidol—Hypotension—Dexamethasone—multiple sclerosis	0.00135	0.00411	CcSEcCtD
Droperidol—Hypotension—Betamethasone—multiple sclerosis	0.00135	0.00411	CcSEcCtD
Droperidol—Hypertension—Prednisone—multiple sclerosis	0.00133	0.00405	CcSEcCtD
Droperidol—Rash—Mitoxantrone—multiple sclerosis	0.00133	0.00405	CcSEcCtD
Droperidol—Dermatitis—Mitoxantrone—multiple sclerosis	0.00133	0.00405	CcSEcCtD
Droperidol—Chills—Methotrexate—multiple sclerosis	0.00133	0.00404	CcSEcCtD
Droperidol—Anxiety—Prednisone—multiple sclerosis	0.00131	0.00398	CcSEcCtD
Droperidol—Hypersensitivity—Prednisolone—multiple sclerosis	0.00127	0.00389	CcSEcCtD
Droperidol—Body temperature increased—Triamcinolone—multiple sclerosis	0.00126	0.00383	CcSEcCtD
Droperidol—Anaphylactic shock—Prednisone—multiple sclerosis	0.00126	0.00383	CcSEcCtD
Droperidol—Shock—Prednisone—multiple sclerosis	0.00124	0.00377	CcSEcCtD
Droperidol—Tachycardia—Prednisone—multiple sclerosis	0.00123	0.00374	CcSEcCtD
Droperidol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00117	0.00357	CcSEcCtD
Droperidol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00117	0.00357	CcSEcCtD
Droperidol—Dizziness—Prednisolone—multiple sclerosis	0.00114	0.00349	CcSEcCtD
Droperidol—Body temperature increased—Dexamethasone—multiple sclerosis	0.00114	0.00348	CcSEcCtD
Droperidol—Body temperature increased—Betamethasone—multiple sclerosis	0.00114	0.00348	CcSEcCtD
Droperidol—Rash—Prednisolone—multiple sclerosis	0.00109	0.00333	CcSEcCtD
Droperidol—Dermatitis—Prednisolone—multiple sclerosis	0.00109	0.00332	CcSEcCtD
Droperidol—Dizziness—Triamcinolone—multiple sclerosis	0.00105	0.00321	CcSEcCtD
Droperidol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00105	0.0032	CcSEcCtD
Droperidol—Dizziness—Methylprednisolone—multiple sclerosis	0.00105	0.0032	CcSEcCtD
Droperidol—Rash—Triamcinolone—multiple sclerosis	0.001	0.00306	CcSEcCtD
Droperidol—Dermatitis—Triamcinolone—multiple sclerosis	0.001	0.00305	CcSEcCtD
Droperidol—Rash—Methylprednisolone—multiple sclerosis	0.001	0.00305	CcSEcCtD
Droperidol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000999	0.00305	CcSEcCtD
Droperidol—Body temperature increased—Prednisone—multiple sclerosis	0.000993	0.00303	CcSEcCtD
Droperidol—Hypotension—Methotrexate—multiple sclerosis	0.000981	0.00299	CcSEcCtD
Droperidol—Dizziness—Betamethasone—multiple sclerosis	0.000954	0.00291	CcSEcCtD
Droperidol—Dizziness—Dexamethasone—multiple sclerosis	0.000954	0.00291	CcSEcCtD
Droperidol—Somnolence—Methotrexate—multiple sclerosis	0.000933	0.00285	CcSEcCtD
Droperidol—Hypersensitivity—Prednisone—multiple sclerosis	0.000926	0.00282	CcSEcCtD
Droperidol—Rash—Dexamethasone—multiple sclerosis	0.00091	0.00277	CcSEcCtD
Droperidol—Rash—Betamethasone—multiple sclerosis	0.00091	0.00277	CcSEcCtD
Droperidol—Dermatitis—Dexamethasone—multiple sclerosis	0.000909	0.00277	CcSEcCtD
Droperidol—Dermatitis—Betamethasone—multiple sclerosis	0.000909	0.00277	CcSEcCtD
Droperidol—Dizziness—Prednisone—multiple sclerosis	0.000831	0.00253	CcSEcCtD
Droperidol—Body temperature increased—Methotrexate—multiple sclerosis	0.00083	0.00253	CcSEcCtD
Droperidol—Rash—Prednisone—multiple sclerosis	0.000792	0.00242	CcSEcCtD
Droperidol—Dermatitis—Prednisone—multiple sclerosis	0.000791	0.00241	CcSEcCtD
Droperidol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000774	0.00236	CcSEcCtD
Droperidol—Dizziness—Methotrexate—multiple sclerosis	0.000694	0.00212	CcSEcCtD
Droperidol—Rash—Methotrexate—multiple sclerosis	0.000662	0.00202	CcSEcCtD
Droperidol—Dermatitis—Methotrexate—multiple sclerosis	0.000661	0.00202	CcSEcCtD
Droperidol—ADRA1A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000219	0.00228	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000216	0.00225	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—RGS1—multiple sclerosis	0.000216	0.00225	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CCR2—multiple sclerosis	0.000213	0.00222	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000212	0.00221	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000211	0.0022	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000211	0.00219	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CCR2—multiple sclerosis	0.00021	0.00218	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000208	0.00216	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000207	0.00216	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000206	0.00214	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GPR65—multiple sclerosis	0.000205	0.00213	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000203	0.00211	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000201	0.00209	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.0002	0.00208	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000197	0.00205	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000197	0.00205	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CNR1—multiple sclerosis	0.000197	0.00205	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RGS1—multiple sclerosis	0.000196	0.00204	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000194	0.00202	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CNR1—multiple sclerosis	0.000194	0.00202	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000193	0.00201	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RGS1—multiple sclerosis	0.000193	0.00201	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	0.00019	0.00197	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	0.000189	0.00196	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000187	0.00195	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000187	0.00195	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GPR65—multiple sclerosis	0.000186	0.00193	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000184	0.00192	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000184	0.00192	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GPR65—multiple sclerosis	0.000183	0.0019	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000181	0.00188	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00018	0.00188	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.00018	0.00188	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.00018	0.00187	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LINGO1—multiple sclerosis	0.00018	0.00187	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	0.000179	0.00186	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000178	0.00185	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—POMC—multiple sclerosis	0.000177	0.00185	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000177	0.00184	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LINGO1—multiple sclerosis	0.000177	0.00184	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000174	0.00181	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000174	0.00181	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	0.000173	0.0018	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000171	0.00178	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR1—multiple sclerosis	0.00017	0.00177	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00017	0.00177	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR1—multiple sclerosis	0.000167	0.00174	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000167	0.00174	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000167	0.00173	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000164	0.0017	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	0.000164	0.0017	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000163	0.0017	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—MAPK1—multiple sclerosis	0.000159	0.00165	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TAGAP—multiple sclerosis	0.000156	0.00162	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TAGAP—multiple sclerosis	0.000153	0.00159	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CCL5—multiple sclerosis	0.000153	0.00159	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CCL5—multiple sclerosis	0.00015	0.00156	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	0.00015	0.00156	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000147	0.00153	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000141	0.00147	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000139	0.00144	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000138	0.00144	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CCR5—multiple sclerosis	0.000138	0.00143	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—S1PR1—multiple sclerosis	0.000136	0.00142	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000136	0.00141	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000136	0.00141	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CCR5—multiple sclerosis	0.000135	0.00141	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—S1PR1—multiple sclerosis	0.000134	0.00139	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000133	0.00138	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000132	0.00138	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GPC5—multiple sclerosis	0.000132	0.00138	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000131	0.00136	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000131	0.00136	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GPC5—multiple sclerosis	0.00013	0.00136	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000128	0.00134	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	0.000128	0.00133	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000126	0.00131	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000124	0.00129	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000124	0.00129	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000122	0.00127	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	0.000121	0.00126	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000121	0.00125	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000119	0.00124	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL3—multiple sclerosis	0.000119	0.00124	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000119	0.00123	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000117	0.00121	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000117	0.00121	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000116	0.00121	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RGS1—multiple sclerosis	0.000116	0.0012	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000115	0.00119	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RGS1—multiple sclerosis	0.000114	0.00119	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000113	0.00117	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000112	0.00117	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	0.000112	0.00116	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000111	0.00116	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000111	0.00115	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GPR65—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000108	0.00113	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GPR65—multiple sclerosis	0.000108	0.00112	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR2—multiple sclerosis	0.000108	0.00112	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—POMC—multiple sclerosis	0.000107	0.00112	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000107	0.00112	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000106	0.0011	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	0.000106	0.0011	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—POMC—multiple sclerosis	0.000106	0.0011	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000106	0.0011	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000105	0.0011	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	0.000105	0.00109	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000104	0.00108	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	0.000104	0.00108	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000103	0.00108	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000101	0.00105	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	0.000101	0.00105	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR1—multiple sclerosis	0.0001	0.00104	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	0.0001	0.00104	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.0001	0.00104	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CNR1—multiple sclerosis	9.94e-05	0.00103	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL13—multiple sclerosis	9.88e-05	0.00103	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR1—multiple sclerosis	9.88e-05	0.00103	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL10—multiple sclerosis	9.86e-05	0.00103	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	9.74e-05	0.00101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	9.67e-05	0.00101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	9.67e-05	0.00101	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	9.65e-05	0.001	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	9.1e-05	0.000947	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	8.95e-05	0.000931	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	8.77e-05	0.000912	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	8.74e-05	0.000909	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	8.63e-05	0.000897	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	8.49e-05	0.000883	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	8.31e-05	0.000864	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	8.15e-05	0.000848	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	7.98e-05	0.00083	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	7.83e-05	0.000815	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	7.77e-05	0.000808	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	7.71e-05	0.000802	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	7.66e-05	0.000797	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	7.65e-05	0.000795	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	7.55e-05	0.000785	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	7.54e-05	0.000784	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	7.49e-05	0.000779	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	7.38e-05	0.000768	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL3—multiple sclerosis	7.15e-05	0.000744	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	7.06e-05	0.000734	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	7.04e-05	0.000732	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	6.95e-05	0.000723	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	6.94e-05	0.000722	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	6.89e-05	0.000717	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	6.89e-05	0.000716	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	6.84e-05	0.000712	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	6.8e-05	0.000707	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PGR—multiple sclerosis	6.78e-05	0.000705	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	6.78e-05	0.000705	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	6.7e-05	0.000697	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PGR—multiple sclerosis	6.67e-05	0.000694	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	6.65e-05	0.000692	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	6.63e-05	0.00069	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CD28—multiple sclerosis	6.59e-05	0.000685	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	6.54e-05	0.000681	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	6.53e-05	0.00068	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CD28—multiple sclerosis	6.48e-05	0.000674	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR2—multiple sclerosis	6.47e-05	0.000673	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	6.41e-05	0.000666	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	6.37e-05	0.000662	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	6.35e-05	0.00066	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	6.23e-05	0.000648	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	6.07e-05	0.000632	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	5.98e-05	0.000622	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CNR1—multiple sclerosis	5.97e-05	0.000621	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	5.87e-05	0.000611	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	5.85e-05	0.000609	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	5.75e-05	0.000598	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—POMC—multiple sclerosis	5.52e-05	0.000574	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	5.43e-05	0.000564	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	5.4e-05	0.000561	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	5.38e-05	0.000559	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	5.31e-05	0.000553	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	5.31e-05	0.000552	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	5.29e-05	0.00055	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	5.2e-05	0.000541	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	5.18e-05	0.000539	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	4.9e-05	0.00051	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	4.82e-05	0.000502	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	4.72e-05	0.000491	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CD86—multiple sclerosis	4.7e-05	0.000489	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL5—multiple sclerosis	4.63e-05	0.000481	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CD86—multiple sclerosis	4.62e-05	0.000481	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	4.55e-05	0.000474	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	4.53e-05	0.000471	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	4.49e-05	0.000467	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	4.46e-05	0.000464	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	4.42e-05	0.00046	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	4.33e-05	0.00045	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SPP1—multiple sclerosis	4.29e-05	0.000446	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	4.22e-05	0.000439	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR5—multiple sclerosis	4.17e-05	0.000434	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	4.13e-05	0.000429	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	4.11e-05	0.000427	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	4.1e-05	0.000427	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL2—multiple sclerosis	4.08e-05	0.000424	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	4.04e-05	0.00042	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	4.02e-05	0.000418	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	4.01e-05	0.000417	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	3.96e-05	0.000412	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	3.93e-05	0.000409	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—multiple sclerosis	3.79e-05	0.000394	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—multiple sclerosis	3.73e-05	0.000388	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	3.65e-05	0.00038	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CD80—multiple sclerosis	3.43e-05	0.000357	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CD80—multiple sclerosis	3.37e-05	0.000351	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	3.3e-05	0.000344	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—POMC—multiple sclerosis	3.26e-05	0.000339	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—POMC—multiple sclerosis	3.21e-05	0.000333	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL2—multiple sclerosis	3.19e-05	0.000332	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	3.14e-05	0.000327	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	3.14e-05	0.000326	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	3.12e-05	0.000324	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	3.07e-05	0.000319	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	3.07e-05	0.000319	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	3e-05	0.000313	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TYK2—multiple sclerosis	2.89e-05	0.000301	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	2.85e-05	0.000296	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	2.79e-05	0.00029	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL2—multiple sclerosis	2.41e-05	0.000251	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—multiple sclerosis	2.4e-05	0.000249	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL2—multiple sclerosis	2.37e-05	0.000247	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	2.36e-05	0.000245	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	2.32e-05	0.000241	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	2.31e-05	0.00024	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—multiple sclerosis	2.28e-05	0.000237	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	2.24e-05	0.000233	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	2.2e-05	0.000228	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STAT3—multiple sclerosis	2.03e-05	0.000211	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	1.99e-05	0.000207	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.95e-05	0.000203	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.88e-05	0.000196	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.88e-05	0.000195	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MYC—multiple sclerosis	1.85e-05	0.000193	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	1.85e-05	0.000192	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.84e-05	0.000192	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1.81e-05	0.000189	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	1.81e-05	0.000189	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	1.81e-05	0.000188	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	1.78e-05	0.000185	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—multiple sclerosis	1.42e-05	0.000147	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—multiple sclerosis	1.39e-05	0.000145	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.36e-05	0.000142	CbGpPWpGaD
